About this Webinar
China is a major active pharmaceutical ingredient (API) and intermediate manufacturer for the global drug industry, with many countries like the US heavily reliant on its API. Join Fiona Barry, Editor of PharmSource of PharmSource, as she explores some of the major trends shaping the Chinese pharmaceutical market today, including manufacturing, COVID-19 vaccine development, and a shift towards innovation.
The webinar will last approximately 60 minutes and will cover:
An overview of China's strong small molecule API manufacturing
China's leading position in COVID-19 vaccine development
Licensing deals involving novel drugs from foreign companies
How China leads in the generation of real-world evidence in clinical trials
Speakers
Fiona Barry
Fiona Barry, MA, is the Associate Editor of PharmSource, responsible for PharmSource’s editorial content and the publication of PharmSource’s Trend Reports, monthly Bio/Pharmaceutical Outsourcing Reports, and quarterly Emerging Market Outsourcing Reports. Fiona previously worked as an investigative journalist for GlobalData’s drug development news service, formerly BioPharm Insight, reporting scoops on clinical trials, contract pharma, rare diseases, and women’s health. She is also an experienced financial journalist and a frequent expert speaker at pharmaceutical industry conferences. Fiona worked for several years as a reporter at William Reed Business Media’s French office, breaking global manufacturing, regulatory, and outsourcing news for the biopharmaceutical industry for in-PharmaTechnologist, Outsourcing-Pharma, and BioPharma Reporter. She holds an MA in English and a BA in English and Philosophy from the University of Bristol, UK.
Past Webinars
View more past webinars
Upcoming Webinars
View more upcoming webinarsStill looking?
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Explorer
Access more premium companies when you subscribe to Explorer